Novartis Negotiates Settlement Of Drug Qui Tam Claims, Takes $700M Charge
BASEL, Switzerland — Swiss drug maker Novartis International AG on July 18 said it is in settlement discussions to resolve false claims allegations with regard to three heart drugs and has...To view the full article, register now.
Already a subscriber? Click here to view full article